A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder

A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder

10.4088/JCR.12m08093

Saved in:

Bibliographic Details
Main Authors:	Cusin, C., Iovieno, N., Iosifescu, D.V., Nierenberg, A.A., Fava, M., Rush, A.J., Perlis, R.H.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110478
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder
by: Perlis, R.H., et al.
Published: (2014)

Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder - Possible Role for Methoxyindole Pathway
by: Zhu, H., et al.
Published: (2014)

Diurnal mood variation in outpatients with major depressive disorder
by: Morris, D.W., et al.
Published: (2014)

Visual contrast sensitivity in major depressive disorder
by: Fam, J., et al.
Published: (2014)

Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: An exploratory analysis of a single-blind randomized trial
by: Davis, L.L., et al.
Published: (2014)

Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
by: Ratti, E., et al.
Published: (2014)

A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints
by: Helen Lavretsky, et al.
Published: (2020)

Clinical characteristics of pramipexole-induced peripheral edema
by: Tan E.-K., et al.
Published: (2018)

Indicators of pretreatment suicidal ideation in adults with major depressive disorder
by: Morris, D.W., et al.
Published: (2014)

The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women
by: Kornstein, S.G., et al.
Published: (2014)

A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence
by: Brown, E.S., et al.
Published: (2014)

Quetiapine monotherapy in acute phase for major depressive disorder: A meta-analysis of randomized, placebo-controlled trials
by: Maneeton N., et al.
Published: (2015)

Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder
by: Garlow, S.J., et al.
Published: (2014)

Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder
by: Cutler, J.A., et al.
Published: (2014)

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and long-term outcomes of a single-blind randomized study
by: Rush, A.J., et al.
Published: (2014)

Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: Results from a double-blind, randomized, and placebo-controlled clinical trial
by: Vahid Farnia, et al.
Published: (2018)

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes
by: Davis, L.L., et al.
Published: (2014)

Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group
by: Han, L.K.M., et al.
Published: (2022)

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report
by: Bobo, W.V., et al.
Published: (2014)

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: Results of the NIMH star*D trial
by: Friedman, E.S., et al.
Published: (2014)

Gender-specific structural abnormalities in major depressive disorder revealed by fixel-based analysis
by: Lyon, M., et al.
Published: (2021)

Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies
by: Uher, R., et al.
Published: (2014)

Family history of depression and therapeutic outcome: Findings from STAR*D
by: Husain, M.M., et al.
Published: (2014)

Effect of pH on Iontophoretic Transport of Pramipexole Dihydrochloride across Human Epidermal Membrane
by: Kamchai Saepang, et al.
Published: (2022)

Profound and reproducible patterns of reduced regional gray matter characterize major depressive disorder
by: Hellewell, S.C., et al.
Published: (2021)

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: A proof of concept
by: Kaddurah-Daouk, R., et al.
Published: (2014)

Major blinding complications of intraocular implantation.
by: Tan, A.Y., et al.
Published: (2016)

Effect of Pulsed Direct Current on Iontophoretic Delivery of Pramipexole across Human Epidermal Membrane In Vitro
by: Kamchai Saepang, et al.
Published: (2022)

Passive and iontophoretic transport of pramipexole dihydrochloride across human skin microchannels created by microneedles in vitro
by: Kamchai Saepang, et al.
Published: (2022)

Correlates of Disability in Asian Patients With Major Depressive Disorder
by: Eurviriyanukul K., et al.
Published: (2015)

Correlates of Disability in Asian Patients With Major Depressive Disorder
by: Eurviriyanukul K., et al.
Published: (2017)

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder
by: Mohammad Haghighi, et al.
Published: (2018)

Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
by: Lim,A., et al.
Published: (2015)

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement
by: Seetal Dodd, et al.
Published: (2018)

Melancholic features and hostility are associated with suicidality risk in Asian patients with major depressive disorder
by: Hong Jin Jeon, et al.
Published: (2018)

Melancholic features and hostility are associated with suicidality risk in Asian patients with major depressive disorder
by: Hong Jin Jeon, et al.
Published: (2018)

Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report
by: Braund, Taylor A., et al.
Published: (2022)

Psychiatric comorbidities in patients with major depressive disorder
by: Papan Thaipisuttikul, et al.
Published: (2018)

Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis
by: George Watt, et al.
Published: (2018)

Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
by: Lim, A.-Y., et al.
Published: (2014)